EditorialSelective Internal Radiotherapy of the Liver: At the Crossroads of Interventional Oncology Research and National Health Service Commissioning
Section snippets
Acknowledgements
The FOXFIRE trial is sponsored by the University of Oxford and is funded the Bobby Moore Fund of Cancer Research UK (CTAAC reference number: CRUK/A16630), an educational grant from Sirtex Medical Ltd and the NIHR Biomedical Research Centre Oxford.
References (10)
- et al.
Radiation oncology and interventional oncology: time for a collaborative approach
Clin Oncol
(2013) - et al.
Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience
Int J Radiat Oncol Biol Phys
(2006) - et al.
Liver metastases from colorectal cancer: radioembolization with systemic therapy
Nat Rev Clin Oncol
(2009) - et al.
Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy
J Clin Oncol
(2007) - et al.
Randomised phase 2 trial of SIR-Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer
J Surg Oncol
(2004)
Cited by (3)
Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A Prospective, Observational Study
2019, Journal of Vascular and Interventional RadiologyAnalysis of a National Programme for Selective Internal Radiation Therapy for Colorectal Cancer Liver Metastases
2019, Clinical OncologyCitation Excerpt :The efficacy of SIRT is supported by an evidence base comprised largely of single-arm studies and three comparative studies (Supplementary Table S1). Commissioning through Evaluation (CtE) is a national programme led by National Health Service (NHS) England that enables highly specialist treatments to be commissioned in selected provider centres with a planned evaluation phase [4]. The evaluation is commissioned by the National Institute for Health and Care Excellence (NICE) and carried out by an independent research group, which assesses the clinical and cost-effectiveness of the intervention in a specific population.
The need for multidisciplinarity in specialist training to optimize future patient care
2017, Nature Reviews Clinical Oncology